◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
ROHTO PHARMACEUTICAL CO.,LTD. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 14, 2025Q4 2024Nov 14, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
+Operating Income 17.8B 21.0B -- -- -- --
Operating Margin % 95.7% 92.5% -- -- -- --
+Ordinary Income 18.6B 22.7B -- -- -- --
Revenue Growth % -18.0% -- -- -- -- --
Line ItemQ4 2025Nov 14, 2025Q4 2024Nov 14, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
Current Assets 217.9B 214.8B -- -- -- --
Total Assets 437.0B 346.2B 335.0B 302.4B 261.5B 215.2B
Current Liabilities 94.6B 87.1B -- -- -- --
Total Liabilities 156.3B 99.1B 96.2B 96.7B 88.9B 67.5B
Total Equity 280.7B 247.0B 238.8B 205.7B 172.6B 147.8B
Equity Ratio -- -- 0.69 0.66 0.64 0.68
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...